Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Atraumatic fractures caused by osteoporosis may be a serious complication of primary biliary cirrhosis. Mean (± S.D.) bone mineral density in the lumbar spine in 210 ambulatory women with primary biliary cirrhosis was 1.02 ± 0.19 gm/cm 2, 7% lower than that in 139 age-matched normal women (after adjustment for age and body weight) (p < 0.001). Bone mineral density in the lumbar spine was inversely related to a risk score index of liver disease severity (r = −0.29, p < 0.001). The mean rate of bone loss in 105 of these 210 women was 2%/yr ± 4%/yr, twice as great as in the 139 normal women (p < 0.02). In 20 women with primary biiary cirrhosis followed up after orthotopic liver transplantation, bone mineral density in the lumbar spine decreased at 3 mo (p < 0.01), and this decrease may have resulted in atraumatic fractures in 13 of them. Bone mineral density in the lumbar spine then increased (p < 0.01) so that by 12 mo the median bone mineral density in the lumbar spine was similar to that before transplantation and by 24 mo it was 5% above it. Therefore we conclude that the progressive bone loss observed in primary biliary cirrhosis (which is further accentuated immediately after transplantation) may be halted, and the bone mass may be restored toward normal within 2 to 3 yr after orthotopic liver transplantation. (HEPATOLOGY 1991;14:296-300.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Osteopenia may worsen for the first 6 months after transplantation, but bone mineral density returns to baseline after 12 months and improves thereafter.(254)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [254]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Applied Regression Analysis and Other Multivariable Methods.
Bhattacharyya, H. T., Kleinbaum, D. G., & Kupper, L. L. (1979) · Journal of the American Statistical Association · doi:10.2307/2287012 · Cited by 1,749
Riggs, B. L., Wahner, H. W., Dunn, W. L., Mazess, R. B., Offord, K. P., & Melton, L. J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110039 · Cited by 1,194
Self-citationPrognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Riggs, B. L., Wahner, H. W., Melton, L. J., Richelson, L. S., Judd, H. L., & Offord, K. P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112462 · Cited by 510
Self-citationAHRENS, E. H., PAYNE, M. A., KUNKEL, H. G., EISENMENGER, W. J., & BLONDHEIM, S. H. (1950) · Medicine · doi:10.1097/00005792-195012000-00002 · Cited by 436
MOVSOWITZ, C., EPSTEIN, S., FALLON, M., ISMAIL, F., & THOMAS, S. (1988) · Endocrinology · doi:10.1210/endo-123-5-2571 · Cited by 404
Clinical Disorders of Bone and Mineral Metabolism
FRAME, B., & MAREL, G. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-5-725 · Cited by 322
Research works printed but not linked: 5
- Cox, 1972, J R Stat Soc, Series B., 34, 248
- Atkinson, 1955, Q J Med, 99, 299
- Stellon, 1985, Q J Med, 57, 783
- Hodgson, 1987, Clin Res, 35, 861a
- Klaushofer, 1987, J Pharmacol Exp Ther, 243, 584
Cited by
Items 101–200 of 296
Clinical features and management of primary biliary cirrhosis
Crosignani, A. L., Battezzati, P. M., Invernizzi, P., Selmi, C. F., Prina, E., & Podda, M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3313 · Cited by 52
Bone Mineral Status in End-Stage Liver Disease and the Effect of Liver Transplantation
Abdelhadi, M., Eriksson, S. A. V., Eriksson, S., Ericzon, B. G., & Nordenström, J. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509101633 · Cited by 49
PRIMARY BILIARY CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS
Angulo, P., & Lindor, K. D. (1999) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70084-2 · Cited by 47
INDICATIONS FOR AND TIMING OF LIVER TRANSPLANTATION
Rosen, H. R., Shackleton, C. R., & Martin, P. B. (1996) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70480-6 · Cited by 47
Risk Factors for Bone Loss in Chronic Active Hepatitis and Primary Biliary Cirrhosis
Olsson, R., Johansson, C., Lindstedt, G., & Mellström, D. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409092505 · Cited by 45
Bone assessment in patients with ileal pouch-anal anastomosis for inflammatory bowel disease
Abitbol, V., Roux, C., Guillemant, S., Valleur, P. D., Hautefeuille, P., Dougados, M., Couturier, D., & Chaussade, S. (1997) · British journal of surgery · doi:10.1002/bjs.1800841117 · Cited by 43
Vargas, A. A., Acevedo, J. M. P., Domingo, I. G., Jiménez, R. G., Martín, J. M. S., Ferrer, M. T., Mota, M. S., Gallego, Á. G., & Gómez‐Bravo, M. Á. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.05.011 · Cited by 45
Extrahepatic manifestations of cholestasis
Glasová, H., & Beuers, U. H. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02717.x · Cited by 49
Krol, C. G., Dekkers, O. M., Kroon, H. M., Rabelink, T. J., van Hoek, B., & Hamdy, N. A. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2214 · Cited by 43
“BMI, kg/m(2), mean (SD) 26 (5) Smoking, n (%) 64 (34) Primary liver disease, n (%) Viral 54 (27) Alcoholic 51 (25) Combined alcoholic and viral 4 (2) Cholestatic (PSC/PBC/overlap syndrome) 29 (14) Malignancy 12 (6) Autoimmune hepatitis 10 (5) Metabolic 7 (3) Other 34 (17) Previous or concomitant renal transplantation,…”
BackgroundLevy, C., & Lindor, K. D. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00097-7 · Cited by 45
“From 3 to 12 months post-OLT, bone mass tends to equal that of the pre-transplant period, and after 12 months the bone mass tends to be higher than before OLT [4].”
BackgroundBeery, R. M. M., Vaziri, H., & Forouhar, F. (2014) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00024 · Cited by 58
“BMD restoration has been demonstrated within the first 2–3 years following LT.(111,137) Successful LT appears to increase bone density over time, particularly in patients who achieve normal hepatic function and whose nutritional status and gonadal hormone levels improve after surgery.”
BackgroundInfluentialOsteoporosis in patients with primary biliary cirrhosis
Wariaghli, G., Allali, F., Maghraoui, A. E., & Hajjaj-Hassouni, N. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283405939 · Cited by 42
Alfacalcidol and Calcitriol in the Prevention of Bone Loss after Organ Transplantation
Sambrook, P. N. (1999) · Calcified Tissue International · doi:10.1007/s002239900709 · Cited by 39
“Several studies have shown correlations between the degree of bone loss and cumulative corticosteroid doses post-transplantation [2, 7].”
BackgroundSelection of patients for liver transplantation
McCaughan, G. W. (1993) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1993.tb01512.x · Cited by 39
Osteoporosis in Chronic Liver Disease
Yadav, A., & Carey, E. J. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533612470145 · Cited by 38
Guañabens, N., Ruiz-Gaspà, S., Gifre, L., Miquel, R., Peris, P., Monegal, A., Dubrueil, M., Arias, A., & Parés, A. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2845 · Cited by 39
“This lowbone formationhasbeenassociatedwith an increase in bone resorption at different stages of the liver disease.((4,16)) In the last years, a molecular signaling involving the Wnt/ ß-catenin has emerged as the main regulator of bone mass and osteoblastogenesis.”
BackgroundPrimary biliary cirrhosis: new perspectives in diagnosis and treatment
Prince, M. I., & Jones, D. E. J. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.894.199 · Cited by 37
“Osteoporosis is commoner in women with PBC than age and sex matched controls.”
Segal, E., Baruch, Y., Kramsky, R., Raz, B., Tamir, A., & Ish‐Shalom, S. (2003) · Clinical Transplantation · doi:10.1034/j.1399-0012.2003.02065.x · Cited by 37
Primary biliary cirrhosis and bone disease
Rosen, H. N. (1995) · Hepatology · doi:10.1002/hep.1840210138 · Cited by 36
Osteoporosis: still a typical complication of primary biliary cirrhosis?
Solerio, E., Isaia, G., Innarella, R., Stefano, M. D. D., Farina, M., Borghesio, E., Framarin, L., Rizzetto, M., & Rosina, F. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00078-1 · Cited by 41
Outcomes After Liver Transplantation: Keep the End in Mind
Bucuvalas, J. C., Campbell, K. M., Cole, C. R., & Guthery, S. L. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000226389.64236.dc · Cited by 38
Campbell, M. S., Lichtenstein, G. R., Rhim, A. D., Pazianas, M., & Faust, T. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01075.x · Cited by 34
Ursodeoxycholic acid decreases bilirubin‐induced osteoblast apoptosis
Ruiz-Gaspà, S., Dubreuil, M., Guañabens, N., Combalía, A., Peris, P., Monegal, A., & Parés, A. R. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12355 · Cited by 37
Chronic Complications of Cholestasis
Assis, D. N. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.03.014 · Cited by 36
Madden, A. M., & Morgan, M. Y. (1997) · Nutrition · doi:10.1016/s0899-9007(97)90877-7 · Cited by 34
Díaz-Guerr, G. M., Gómez, R., Jódar, E., Loinaz, C., and, E. M., & Hawkins, F. G. (2002) · Osteoporosis International · doi:10.1007/s001980200006 · Cited by 34
“This could explain the modest bone loss observed in our patients at the baseline assessment (approximately 10% or –1 SD) compared with similar studies [5,6].”
BackgroundResultGrowth and bone health in chronic liver disease and following liver transplantation in children.
Högler, W., Baumann, U., & Kelly, D. A. (2010) · PubMed · Cited by 33
Smith, D. L. H., Shire, N. J., Watts, N. B., Schmitter, T., Szabo, G., & Zucker, S. D. (2006) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2005.10.001 · Cited by 37
BONE DISEASE IN LIVER TRANSPLANT RECIPIENTS
Hay, J. E. (1993) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00071-6 · Cited by 34
Ruiz-Gaspà, S., Guañabens, N., Jurado, S., Dubreuil, M., Combalía, A., Peris, P., Monegal, A., & Parés, A. R. (2019) · Gene · doi:10.1016/j.gene.2019.144167 · Cited by 35
Osseous complications of pediatric transplantation
Saland, J. M. (2004) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2004.00167.x · Cited by 33
“The bone mineral density declines significantly, particularly at the lumbar spine and proximal femur (predominantly trabecular sites) by 3–6 months after transplantation (75, 76, 176).”
BackgroundLiver Transplantation: The Last Ten Years
Wood, R. P., Ozaki, C. F., Katz, S. M., Johnston, T. D., Monsour, H., & Dyer, C. H. (1994) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)46437-6 · Cited by 35
Indications for liver transplantation in primary biliary cirrhosis
Benhamou, J. P. (1994) · Hepatology · doi:10.1016/0270-9139(94)90266-6 · Cited by 31
Boulton‐Jones, J. R., Fenn, R., West, J., Logan, R. F., & Ryder, S. D. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02089.x · Cited by 33
Benetti, A., Crosignani, A., Varenna, M., Giussani, C. S., Allocca, M., Zuin, M., Podda, M., & Battezzati, P. M. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000248017.31386.39 · Cited by 31
“These findings are in line with those reported by some authors,12,22,23 but markedly differ from those observed by others.(6,8,11,24,25) However, none of such studies could provide accurate and unbiased estimates of bone demineralization in PBC as most of them were based on cross-sectional evaluations, patients with e…”
ResultWeinreb, M., Pollak, R. D., & Ackerman, Z. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.032 · Cited by 33
Withold, W., Wolf, H., Kollbach, S., Heyll, A., Schneider, W., & Reinauer, H. (1996) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1996.34.3.193 · Cited by 30
“Reduced bone mineral density is a common finding in patients following liver, cardiac and bone marrow transplantation (2, 16-18).”
BackgroundFisher, L., Byrnes, E., & Fisher, A. A. (2009) · Nutrition Research · doi:10.1016/j.nutres.2009.09.001 · Cited by 32
“In patients with various CLD, serum bilirubin correlated with OC [34], bone mineral density [35], and bone loss [36,37].”
BackgroundSethi, A., & Stravitz, R. T. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03166.x · Cited by 30
Osteoporosis: Pathophysiology, prevention, diagnosis, and treatment
Odell, W. D., & Heath, H. (1993) · Disease-a-Month · doi:10.1016/0011-5029(93)90021-t · Cited by 31
Guañabens, N., Monegal, A., Muxí, Á., Martinez-Ferrer, A., Reyes, R., Caballería, J., del Río, L., Peris, P., Pons, F., & Parés, A. R. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1756-1 · Cited by 33
“In addition, it has been reported that BMD measurements with dual photon absorptiometry, using (153)Gd as the source in patients with an abdominal diameter higher than 27 cm are unreliable [25].”
BackgroundSchmidt, T., Schmidt, C., Schmidt, F. N., Butscheidt, S., Mussawy, H., Hubert, J., Hawellek, T., Oehler, N., Barvencik, F., Lohse, A. W., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3410 · Cited by 30
“To our knowledge, these data are the first to describe abnormal microarchitectural changes in both cortical and trabecular compartments associated with the severity of PBC. HR-pQCT represents a precise tool to assess the bonemicroarchitecture of PBC patients and can therefore identify the PBC patients at high risk for…”
MethodInfluentialNutritional and metabolic issues in cirrhosis and liver transplantation
Cabré, E., & Gassull, M. A. (2000) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200009000-00004 · Cited by 29
Gonchoroff, D. G., Branum, E. L., Cedel, S. L., Riggs, B. L., & O’Brien, J. F. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90007-y · Cited by 29
Self-citationImmunosuppressive therapy and the skeleton
Shane, E., & Epstein, S. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90015-9 · Cited by 28
Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges
Trivedi, H. D., Danford, C. J., Goyes, D., & Bonder, A. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s204638 · Cited by 33
The Prevention of Bone Fractures After Liver Transplantation: Experience With Alendronate Treatment
Atamaz, F. C., Hepgüler, S., Karasu, Z. A., Kilic, M., & Tokat, Y. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.02.074 · Cited by 27
Increased rate of bone loss at the femoral neck in patients with chronic liver disease
Ormarsdóttir, S., Ljunggren, Ö., Mallmin, H., Michaëlsson, K., & Lööf, L. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200201000-00008 · Cited by 30
Vedi, S., Ninkovic, M., Garrahan, N. J., Alexander, G. J. M., & Compston, J. E. (2002) · Transplant International · doi:10.1111/j.1432-2277.2002.tb00167.x · Cited by 27
Guardiola, J., Xiol, X., Sallie, R., Solé, J. M. N., Roig-Escofet, D., Jaurrieta, E., & Casais, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-10-199911160-00006 · Cited by 27
“The underlying bone disorder is a composite of the osteoporosis associated with chronic liver disease (4) and the rapid additional bone loss that occurs in the first few months after transplantation (1, 2, 5).”
BackgroundBone mineral metabolism and histomorphometry in rats with cholestatic liver disease
Ackerman, Z., Weinreb, M., Amir, G., & Pollak, R. D. (2002) · Liver International · doi:10.1046/j.0106-9543.2002.01566.x · Cited by 26
Current and future treatments of secondary osteoporosis
Soriano, R., Herrera, S., Nogués, X., & Díez‐Pérez, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.004 · Cited by 29
Liver Transplant for Cholestatic Liver Diseases
Carrion, A. F., & Bhamidimarri, K. R. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.12.005 · Cited by 25
Fracture incidence after liver transplantation: results of a 10-year audit
Premaor, M. O., Das, T., Debiram, I., Parker, R. A., Ninkovic, M., Alexander, G., & Compston, J. E. (2011) · QJM · doi:10.1093/qjmed/hcr025 · Cited by 24
“Spine 11 (55) Wrist 2 (10) Humerus 1 (5) Hip 1 (5) Lower leg 1 (5) Hand 1 (5) Ribs 1 (5) Sacrum 1 (5) Ischial tuberosity 1 (5) 602 M.”
Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease.
Gars, L. L., Grandpierre, C., Chazouilleres, O., Berenbaum, F., & Poupon, R. (2002) · Joint, bone, spine : revue du rhumatisme · doi:10.1016/s1297-319x(02)00364-0 · Cited by 28
Association between primary biliary cholangitis and osteoporosis: meta-analysis
Fan, J., Wang, Q., & Sun, L. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3844-x · Cited by 26
“[13] (1991) USA F 48 ± 10, 51 ± 15 Case-control 210/139 Lumbar spine BMD”
Lim, W. H., Ng, C. H., Ow, Z. G. W., Ho, O. T. W., Tay, P. W. L., Wong, K. L., Tan, E. X. X., Tang, S. Y., Teo, C. M., & Muthiah, M. D. (2021) · Transplant International · doi:10.1111/tri.13863 · Cited by 29
Monegal, A., Navasa, M., Peris, P., Colmenero, J., Cuervo, A. M., Muxí, Á., Gifre, L., & Guañabens, N. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9797-4 · Cited by 24
Ursodeoxycholic Acid Enhances Fractional Calcium Absorption in Primary Biliary Cirrhosis
Verma, A. M., Maxwell, J. D., Ang, L., Davis, T., Hodges, S. J., Northfield, T. C., Zaidi, M., & Pazianas, M. (2002) · Osteoporosis International · doi:10.1007/s001980200092 · Cited by 22
“In conclusion, a better understanding of the pathophysiology of bone disease in PBC should have a profound impact on its prevention and treatment, considering that the rates of bone loss can be as high as twice that of the normal population [ 4 ].”
BackgroundGuadalix, S., Diaz‐Guerra, G. M., Lora, D., Vargas, C., Gómez‐Juaristi, M., Cobaleda, B., González, E. M., & Hawkins, F. G. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01253.x · Cited by 23
“Greater bone loss at vertebral and hip sites and high rates of incident fragility fractures have been reported [4,5].”
Liver Transplantation in Primary Biliary Cirrhosis: Risk Assessment and 11-Year Follow-Up
Rust, C., Rau, H. G., Gerbes, A. L., Pape, G. R., Haller, M., Krämling, H.-J., Schildberg, F. W., Paumgartner, G., & Beuers, U. H. (2000) · Digestion · doi:10.1159/000007776 · Cited by 26
“Female patients with PBC have a reduced mean bone density when compared to healthy women [”
BackgroundJones, D. E., James, O., & Bassendine, M. F. (1998) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70007-6 · Cited by 26
Räkel, A., Sheehy, O., Rahme, E., & LeLorier, J. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070723 · Cited by 21
LONG-TERM CARE OF THE LIVER TRANSPLANT RECIPIENT
Muñoz, S. J., Rothstein, K. D., Reich, D. J., & Manzarbeitia, C. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70133-1 · Cited by 21
Clinical significance of recurrent primary biliary cirrhosis after liver transplantation
Knoop, M., Bechstein, W. O., Schrem, H., Lobeck, H., Hopf, U., & Neuhaus, P. (1996) · Transplant International · doi:10.1111/j.1432-2277.1996.tb01586.x · Cited by 22
Shane, E. J., & Epstein, S. (2001) · Transplantation Reviews · doi:10.1053/trre.2001/19535 · Cited by 21
Extrahepatic Manifestations of Cholestatic Liver Diseases: Pathogenesis and Therapy
Pusl, T., & Beuers, U. H. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:147 · Cited by 22
Hormone replacement for osteoporosis in women with primary biliary cirrhosis
Rudić, J. S., Poropat, G., Krstic, M. N., Bjelaković, G., & Gluud, C. N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009146.pub2 · Cited by 21
Bone disease after liver transplantation
Crippin, J. S. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.28516 · Cited by 19
Management of osteoporosis in primary biliary cirrhosis
Wolfhagen, F. H. J., van Buuren, H. R., Vleggaar, F. P., & Schalm, S. W. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2000.0108 · Cited by 21
Clinical significance of recurrent primary biliary cirrhosis after liver transplantation
Knoop, M., Bechstein, W. O., Schrem, H., Neuhaus, P., Lobeck, H., & Hopf, U. (1996) · Springer eBooks · doi:10.1007/978-3-662-00818-8_30 · Cited by 18
Withold, W., Wolf, H., Kollbach, S., Heyll, A., Schneider, W., & Reinauer, H. (1996) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1996.34.4.295 · Cited by 18
Monthly Ibandronate for the Prevention of Bone Loss in Patients After Liver Transplantation
Kaemmerer, D., Schmidt, B., Lehmann, G., Wolf, G. L., Hommann, M., & Settmacher, U. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.01.133 · Cited by 17
Ulivieri, F. M., Lisciandrano, D., Gridelli, B. G., Lucianetti, A., Roggero, P., Nebbia, G., Cataliotti, E., Prato, P., Mauro, P. D., Campanini, F., et al. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(99)00285-7 · Cited by 17
R eview : Treatment of primary biliary cirrhosis
Heathcote, J. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00300.x · Cited by 18
Primary biliary cirrhosis: Clarifying the issues
Sherlock, S. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90187-2 · Cited by 20
Shah, S. H., Johnston, T. D., Jeon, H., & Ranjan, D. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.04.032 · Cited by 16
“1 percent/year, with the most rapid bone loss confined to the first 3–6 months post-transplant [9].”
BackgroundBone loss after organ transplantation
Julian, B. A., Benfield, M. R., & Quarles, L. D. (1993) · Transplantation Reviews · doi:10.1016/s0955-470x(05)80042-4 · Cited by 17
Post-liver transplantation osteoporosis
Cheung, A. M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00070-2 · Cited by 16
Indications for liver transplantation in primary biliary cirrhosis
Benhamou, J. (1994) · Hepatology · doi:10.1002/hep.1840200705 · Cited by 31
Treatment Options for Osteoporosis in Chronic Liver Disease Patients Requiring Liver Transplantation
Ng, T. M. H., & Bajjoka, I. E. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17405 · Cited by 15
Gür, A., Dikici, B., Nas, K., Boşnak, M., Haspolat, K., & Saraç, A. J. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-30 · Cited by 15
“activity of osteoblasts [21], there are also studies indicating an increase in osteoclast activity [22].”
BackgroundRheumatic complications following liver transplantation
Taillandier, J., Alemanni, M., Samuel, D., & Bismuth, H. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(99)00075-5 · Cited by 14
Menopause and gastrointestinal health and disease
Ley, D., & Saha, S. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01075-7 · Cited by 19
Bone disease after liver transplantation.
Losowsky, M. S., & Hussaini, S. H. (1996) · Gut · doi:10.1136/gut.39.4.505 · Cited by 14
Ionele, C. M., Turcu-Ştiolică, A., Subtirelu, M. S., Ungureanu, B. S., Cioroianu, G. O., & Rogoveanu, I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133807 · Cited by 13
“Only one study [30] reported higher BMD–LS in PSC than PBC, which might be related to the severity index for liver disease as assessed by a score based on multiple risk factors exemplified in 210 PBC [42] and 37 PSC patients [43].”
BackgroundManagement of Primary Biliary Cirrhosis and Autoimmune Cholangitis
Angulo, P., & Lindor, K. D. (1998) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70011-8 · Cited by 14
Lazaridis, K. N., & Lindor, K. D. (1999) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-999-0051-0 · Cited by 12
Henson, J. B., & King, L. Y. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.07.009 · Cited by 12
Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation
Kaemmerer, D., Schmidt, B., Lehmann, G., Wolf, G., Settmacher, U., & Hommann, M. (2012) · Transplantation Research · doi:10.1186/2047-1440-1-7 · Cited by 14
“The probability of bone fractures in the course of the post-transplant period has been reported as ranging from 6% to 65% [14-17].”
BackgroundOsteoporosis and Jaw Abnormalities in Panoramic Radiography of Chronic Liver Failure Patients
Ghapanchi, J., Zahed, M., Haghnegahdar, A., Niakan, N., & Sadeghzadeh, A. (2018) · BioMed Research International · doi:10.1155/2018/4280312 · Cited by 15
Osteoporosis in Gastrointestinal, Pancreatic, and Hepatic Diseases
Bikle, D. D. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50049-0 · Cited by 12
Ahmed, A., & Mayo, M. J. (2014) · Clinical gastroenterology · doi:10.1007/978-1-4939-1013-7_9 · Cited by 11
Medical Management of the Liver Transplant Recipient
Stravitz, R. T., Carl, D. E., & Biskobing, D. M. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.08.007 · Cited by 11
High incidence of vertebral osteoporotic fracture within the first year after liver transplantation.
Butin, S., Griffoul, I., Espitalier, F., Salamé, E., Mulleman, D., & Goupille, P. (2017) · PubMed · Cited by 11
Metabolic Bone Disease in the Post-transplant Population
Nel, J. D., & Epstein, S. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.01.007 · Cited by 9
Bone mineral density following liver transplantation: a 10-year trend analysis
Li, X. Y., Lew, C. C. H., & Kek, P. C. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-021-01037-x · Cited by 10
Post-Transplantation Bone Disease
Federico, G., Guadalix, S., Sanchez, R., & Martínez, G. (2012) · InTech eBooks · doi:10.5772/29672 · Cited by 7
“1 Glucocorticoids Early bone loss has been observed in all solid organ transplants in the first 3 to 6 months, increasing the incidence of osteoporosis and osteopenia (Rodino et al., 1998; Leidig-Bruckner et al., 2001; Eastell et al., 1991).”
BackgroundTransplantation Osteoporosis: Biochemical Correlates of Pathogenesis and Treatment
Kulak, C. A. M., & Shane, E. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012088562-6/50043-1 · Cited by 8
Ormarsdóttir, S., Ljunggren, Ö., Mallmin, H., Olsson, R., Prytz, H., & Lööf, L. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01066.x · Cited by 9
Metadata
- Authors
- Eastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F.
- Affiliations
- Mayo Clinic (US)
- Venue
- Hepatology
- Published
- 1991-08
- Volume
- 14
- Issue
- 2
- Pages
- 296-300
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1982221537
- Cited by
- 297
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 8797 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01am033230-02)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- primary biliary cirrhosis, osteoporosis, bone mineral density, vertebral bone loss, liver transplantation, atraumatic fractures, lumbar spine, women, liver disease severity
- MeSH terms
- Female, Humans, Liver Cirrhosis, Biliary, Middle Aged, Osteoporosis, Postoperative Period, Spinal Diseases, Absorptiometry, Photon, Liver Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.